Tizon, Baby Girl I .
HRN: 25-50-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2024
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/25/2024
08/01/2024
IV
17mg LD; 8mg MD
OD
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes